NFE2L2 and cancer: Elevation of Nrf2 levels has been shown in clinical studies in cancer such as lung, ovarian, melanoma, colorectal cancer, endometrial carcinoma, breast cancer, kidney cancer, pancreatic cancer, endometrial carcinoma, and hepatocellular carcinoma [22].